Xylem (NYSE: XYL) reported Q2 EPS of $0.66, $0.12 better than the analyst estimate of $0.54. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.32 billion.

GUIDANCE:

Xylem sees FY2022 EPS of $2.50-$2.70, versus prior of $2.40-$2.70 and the consensus of $2.56.

For earnings history and earnings-related data on Xylem (XYL) click here.